Cargando…
The Current Status of Myeloid Growth Factor Therapy
Supralethal chemotherapy has been used in an attempt to cure certain malignancies by employing doses of cytotoxic agents beyond conventional limits. The resulting damage to the bone marrow requires rescue with an infusion of autologous or allogenic marrow to repopulate the haemopoietic system. The r...
Autor principal: | Galvani, D. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of Physicians of London
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377111/ https://www.ncbi.nlm.nih.gov/pubmed/1717684 |
Ejemplares similares
-
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2018) -
Third-line therapy for chronic myeloid leukemia: current status and future directions
por: Cortes, Jorge, et al.
Publicado: (2021) -
Current status of immunotherapy in acute myeloid leukemia
por: Subklewe, Marion
Publicado: (2018) -
Current Status of Biological Treatment in Ankylosing Spondylitis Patients and Some Related Factors
por: Binh, Bui Hai, et al.
Publicado: (2023) -
Current status of hematopoietic stem cell transplant in chronic myeloid leukemia
por: Gupta, Alok, et al.
Publicado: (2014)